Immunic Ag

This study tests an oral medication called IMU-838 against a placebo in about 1,100 adults with relapsing multiple sclerosis (MS). The goal is to see if the drug can reduce the number of relapses and brain lesions over 72 weeks. Participants must be 18-55 years old and have had r…

This study tests an experimental drug called IMU-838 against a placebo in over 1,100 adults with relapsing multiple sclerosis. The goal is to see if the drug can delay or prevent relapses and reduce new brain lesions seen on MRI. Participants take the pill daily for up to 72 week…